This is an open-access article distributed under the terms of the Creative Commons Attribution License.Significant advances have been achieved in recent years in the identification of the genetic and the molecular alterations of pancreatic ductal adenocarcinoma (PDAC). Despite this, at present the understanding of the precise mechanisms involved in the development and malignant transformation of PDAC remain relatively limited. Here, we evaluated for the first time, the molecular heterogeneity of PDAC tumors, through simultaneous assessment of the gene expression profile (GEP) for both coding and non-coding genes of tumor samples from 27 consecutive PDAC patients. Overall, we identified a common GEP for all PDAC tumors, characterized by an i...
We performed integrated genomic, transcriptomic, and proteomic profiling of 150 pancreatic ductal ad...
Pancreatic ductal adenocarcinoma (PDAC) is one of the leading causes of cancer death due to limited ...
We performed integrated genomic, transcriptomic, and proteomic profiling of 150 pancreatic ductal ad...
Pancreatic ductal adenocarcinoma (PDAC) has an extremely poor prognosis due to the lack of methods o...
With less than a 5% survival rate pancreatic adenocarcinoma (PDAC) is almost uniformly lethal. In or...
© 2021 by the authors.Pancreatic ductal adenocarcinoma (PDAC) is one of the leading causes of cancer...
ABSTRACT: BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) is a heterogeneous cancer in which dif...
PhD Theses MedicalPancreatic ductal adenocarcinoma (PDAC) remains one of the most aggressive and le...
Pancreatic Ductal Adenocarcinoma (PDAC) is the fourth most common cause of cancer-related death and ...
Pancreatic ductal adenocarcinoma (PDAC) is an extremely malignant tumor. The immune profile of PDAC ...
Pancreatic ductal adenocarcinoma (PDAC) is predicted to become the second leading cause of cancer-re...
Pancreatic Ductal Adenocarcinoma (PDAC) is the fourth most common cause of cancer-related death and ...
Improving the survival of patients with pancreatic ductal adenocarcinoma (PDAC) remains an oncologic...
Improving the survival of patients with pancreatic ductal adenocarcinoma (PDAC) remains an oncologic...
Pancreatic ductal adenocarcinoma (PDAC) is a biologically aggressive malignancy showing a remarkable...
We performed integrated genomic, transcriptomic, and proteomic profiling of 150 pancreatic ductal ad...
Pancreatic ductal adenocarcinoma (PDAC) is one of the leading causes of cancer death due to limited ...
We performed integrated genomic, transcriptomic, and proteomic profiling of 150 pancreatic ductal ad...
Pancreatic ductal adenocarcinoma (PDAC) has an extremely poor prognosis due to the lack of methods o...
With less than a 5% survival rate pancreatic adenocarcinoma (PDAC) is almost uniformly lethal. In or...
© 2021 by the authors.Pancreatic ductal adenocarcinoma (PDAC) is one of the leading causes of cancer...
ABSTRACT: BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) is a heterogeneous cancer in which dif...
PhD Theses MedicalPancreatic ductal adenocarcinoma (PDAC) remains one of the most aggressive and le...
Pancreatic Ductal Adenocarcinoma (PDAC) is the fourth most common cause of cancer-related death and ...
Pancreatic ductal adenocarcinoma (PDAC) is an extremely malignant tumor. The immune profile of PDAC ...
Pancreatic ductal adenocarcinoma (PDAC) is predicted to become the second leading cause of cancer-re...
Pancreatic Ductal Adenocarcinoma (PDAC) is the fourth most common cause of cancer-related death and ...
Improving the survival of patients with pancreatic ductal adenocarcinoma (PDAC) remains an oncologic...
Improving the survival of patients with pancreatic ductal adenocarcinoma (PDAC) remains an oncologic...
Pancreatic ductal adenocarcinoma (PDAC) is a biologically aggressive malignancy showing a remarkable...
We performed integrated genomic, transcriptomic, and proteomic profiling of 150 pancreatic ductal ad...
Pancreatic ductal adenocarcinoma (PDAC) is one of the leading causes of cancer death due to limited ...
We performed integrated genomic, transcriptomic, and proteomic profiling of 150 pancreatic ductal ad...